undamentalytics Newsletter
Sign in

Waystar Holding Corp. revenue

Waystar Holding Corp.'s revenue was $1.10bn in fiscal 2025, up 16.5% on the year before. Since fiscal 2022 ($705m) it has grown at a compound 16.0% a year. Over the last twelve months it was $1.26bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue7057919441,0991,263
Growth on the year before—+12.2%+19.3%+16.5%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Subscriptions $558M 50.8% ▲ 21.9%
Volume Based Revenue $535M 48.6% ▲ 11.4%
Implementation Services and Other Revenue $6.1M 0.6% ▲ 8.0%

From Waystar Holding Corp.'s 10-K filed February 17, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Technology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Waystar Holding Corp. $1.26bn 21.4% —
Omnicell, Inc. $1.25bn 8.5% 0.3%
Tempus AI, Inc. $1.51bn 36.6% —
Goodrx Holdings, Inc. $785m -1.8% 1.8%
Doximity, Inc. $656m 11.2% 14.5%
Teladoc Health, Inc. $2.47bn -2.4% -1.5%

Compare with peers

Head to head: OMCL vs WAYTEM vs WAYGDRX vs WAYTDOC vs WAY

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Waystar Holding Corp.'s SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Waystar Holding Corp.